While 3-FEA has not been formally researched on the same stage as conventional amphetamines, it is at the moment assumed that like other substituted amphetamines with substitutions at identical positions, it most certainly functions primarily like a triple reuptake inhibitor and/or releaser with the monoamine neurotransmitters serotonin, dopamine, and norepinephrine. https://stevec208bnt1.dgbloggers.com/profile